Citation Impact
Citing Papers
TUBERCULOSIS IN TROPICAL AFRICA. AN EPIDEMIOLOGICAL STUDY.
1964
The booster phenomenon in serial tuberculin testing.
1979 Standout
The success and failure of BCG — implications for a novel tuberculosis vaccine
2005
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
2016 Standout
The Tuberculin Skin Test
1993 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
The BCG Story: Lessons from the Past and Implications for the Future
1989
Mannose-Binding Protein B Allele Confers Protection against Tuberculous Meningitis
1999
The Influence of Calmette-Guérin Bacillus Immunization on the Booster Effect of Tuberculin Testing in Healthy Young Adults
1990
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
2006 Standout
Relative persistence capacity of BCG substrains in mouse spleen. Computerized statistical analysis. Multiple comparison
1992
Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review
2004 Standout
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
Guideline for Infection Control in Healthcare Personnel, 1998
1998
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Outlier and influence diagnostics for meta-analysis
2010 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Evolution and Current Use of the Tuberculin Test
2002
Complement
2001 Standout
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
New use of BCG for recombinant vaccines
1991 StandoutNature
Guideline for infection control in health care personnel, 1998
1998
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active‐surveillance report
2003 Standout
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
2009 Standout
Interpretation of the tuberculin skin test
1995 Standout
The Growing Burden of Tuberculosis
2003 Standout
Adsorption of tuberculin PPD to glass and plastic surfaces.
1966
Delineation of Nocardia farcinica by Delayed Type Skin Reactions on Guinea Pigs
1968
Disease and “development” in Africa
1970 Standout
Frequency of Negative Intermediate-Strength Tuberculin Sensitivity in Patients with Active Tuberculosis
1971
Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research
2007 Standout
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
Numerical Taxonomy of Some Nocardioform Bacteria
1971 Standout
Epidemiologic basis of tuberculosis control
1999
Efficacy of BCG Vaccine in the Prevention of Tuberculosis
1994 Standout
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
2014
The tuberculin skin test.
1982
Contributions of Northern Populations to the Understanding of Tuberculin Sensitivity
1968
Diagnostic and Prognostic Significance of the Quantitative Tuberculin Tests
1967
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
The Immune Response in Tuberculosis
2013 Standout
A demonstration of lack of variability among six tuberculin skin test readers.
1985
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Genomic insights that advance the species definition for prokaryotes
2005 Standout
Deoxyribonucleic Acid Relatedness Among Selected Strains of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium bovis BCG, Mycobacterium microti, and Mycobacterium africanum
1985
The BCG Controversy
1983
Tuberculin Test in Retrospect and Prospect
1967
Bacille Calmette-Guérin Vaccinations and Tuberculin Skin Tests
1985
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.
1999 Standout
Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area.
1969
Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant
2007 StandoutNobel
Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety.
1990
The Continuing Challenges of Leprosy
2006 Standout
Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series.
1999
Works of J Guld being referenced
Standardization of a new batch of purified tuberculin (PPD) intended for international use.
1958
Stability of purified tuberculin in high dilution.
1958
The duration of BCG-induced tuberculin sensitivity in children, and its irrelevance for revaccination. Results of two 5-year prospective studies.
1968
The effect of Tween 80 on intradermal tuberculin reactions.
1965
Quantitative aspects of the intradermal tuberculin test in humans. II. The relative importance of accurate injection technique.
1954
Adsorption of tuberculin to glass.
1958
The WHO tuberculin test.
1964
The virulence of some strains of BCG for golden hamsters. Further studies.
1970
Duration of allergy and immunity in BCG-vaccinated guinea pigs. A five-year study.
1967
Present knowledge of immunization against tuberculosis.
1976
The protective effect in bank voles of some strains of BCG.
1970
The virulence of some strains of BCG for golden hamsters.
1968
Diluents for stabilization of tuberculin.
1958
Correlation of tuberculin sensitivity before and after BCG vaccination.
1966